Ionis Pharmaceuticals
IONS
IONS
293 hedge funds and large institutions have $5.68B invested in Ionis Pharmaceuticals in 2017 Q2 according to their latest regulatory filings, with 47 funds opening new positions, 93 increasing their positions, 91 reducing their positions, and 22 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
more funds holding
Funds holding: →
2% more repeat investments, than reductions
Existing positions increased: 93 | Existing positions reduced: 91
0.47% more ownership
Funds ownership: 89.64% → 90.11% (+0.47%)
8% less call options, than puts
Call options by funds: $56.9M | Put options by funds: $62.1M
Holders
293
Holding in Top 10
6
Calls
$56.9M
Puts
$62.1M
Top Buyers
| 1 | +$58.1M | |
| 2 | +$37M | |
| 3 | +$21.2M | |
| 4 |
BlackRock
New York
|
+$13.4M |
| 5 |
SGAM
Smith Group Asset Management
Dallas,
Texas
|
+$11.4M |
Top Sellers
| 1 | -$37.5M | |
| 2 | -$19.2M | |
| 3 | -$18.6M | |
| 4 |
Renaissance Technologies
New York
|
-$11.7M |
| 5 |
SI
Scout Investments
Kansas City,
Missouri
|
-$8.89M |